Tyler Jacks, Cancer Moonshot Panel Co-Chair, Discusses Roadmap
Xconomy
SEPTEMBER 9, 2016
But is there a danger of relying too heavily just on genomics to determine the course of a patient’s treatment? X : This sounds a lot like the GENIE project to pool patient data among seven top cancer centers. GENIE is one of several ongoing. And in many patients there are mutations without appropriate drugs.
Let's personalize your content